All Stories

  1. Detecting latent tuberculosis in compromised patients

    Article • Current Opinion in Infectious Diseases, June 2015, Wolters Kluwer Health

    PhD Ilria Sauzullo

  2. Long-term IFN-γ and IL-2 response for detection of latent tuberculosis infection in healthcare workers with discordant immunologic results

    Article • Journal of Immunological Methods, December 2014, Elsevier

    PhD Ilria Sauzullo

  3. FRI0268 Multifunctional Flow Cytometry Analysis of CD4+ T Cells as an Immune Biomarker for Latent Tuberculosis Status in Patients Treated with TNF Antagonists

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    PhD Ilria Sauzullo

  4. The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature

    Article • Clinical Rheumatology, May 2014, Springer Science + Business Media

    PhD Ilria Sauzullo

  5. Multi-functional flow cytometry analysis of CD4+T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists

    Article • Clinical & Experimental Immunology, April 2014, Wiley

    PhD Ilria Sauzullo

  6. Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy

    Article • Archivio Italiano di Urologia e Andrologia, December 2013, PAGEPress Publications

    PhD Ilria Sauzullo

  7. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists:in vivoandin vitroanalysis

    Article • British Journal of Dermatology, October 2013, Wiley

    PhD Ilria Sauzullo

  8. Mycobacterial Interferon-  Release Variations During Longterm Treatment with Tumor Necrosis Factor Blockers: Lack of Correlation with Clinical Outcome

    Article • The Journal of Rheumatology, December 2012, The Journal of Rheumatology

    PhD Ilria Sauzullo

  9. Serial interferon-γ release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents

    Article • Clinical Rheumatology, August 2012, Springer Science + Business Media

    PhD Ilria Sauzullo

  10. In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells

    Article • Clinical & Experimental Immunology, October 2011, Wiley

    PhD Ilria Sauzullo

  11. Influence of previous tuberculin skin test on serial IFN-γ release assays

    Article • Tuberculosis, July 2011, Elsevier

    PhD Ilria Sauzullo

  12. Severe and Persistent Depletion of Circulating Plasmacytoid Dendritic Cells in Patients with 2009 Pandemic H1N1 Infection

    Article • PLoS ONE, May 2011, PLOS

    PhD Ilria Sauzullo

  13. Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins

    Article • Multiple Sclerosis Journal, August 2010, SAGE Publications

    PhD Ilria Sauzullo

  14. Detection of interleukin-2 in addition to interferon-γ discriminates active tuberculosis patients, latently infected individuals, and controls

    Article • Clinical Microbiology and Infection, August 2010, Elsevier

    PhD Ilria Sauzullo

  15. Downregulation of Leukocyte Migration After Treatment With CCR5 Antagonist Maraviroc

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2010, Wolters Kluwer Health

    PhD Ilria Sauzullo

  16. Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist

    Article • Microbiologia Medica, June 2010, PAGEPress Publications

    PhD Ilria Sauzullo

  17. CXCL10/IP10 is a novel potential in vitro marker of TB infection

    Article • Microbiologia Medica, June 2009, PAGEPress Publications

    PhD Ilria Sauzullo

  18. Correction: Accuracy of Immunodiagnostic Tests for Active Tuberculosis Using Single and Combined Results: A Multicenter TBNET-Study

    Article • PLoS ONE, June 2009, PLOS

    PhD Ilria Sauzullo

  19. In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-γ T Cell Response

    Article • PLoS ONE, April 2009, PLOS

    PhD Ilria Sauzullo, Dr Marco Iannetta

  20. Rapid identification of mycobacterial species directly in clinical samples

    Article • Microbiologia Medica, December 2008, PAGEPress Publications

    PhD Ilria Sauzullo

  21. QuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis

    Article • Diagnostic Microbiology and Infectious Disease, December 2008, Elsevier

    PhD Ilria Sauzullo

  22. Inhibitory activity ofMelissa officinalisL. extract onHerpes simplexvirus type 2 replication

    Article • Natural Product Research, November 2008, Taylor & Francis

    PhD Ilria Sauzullo

  23. Accuracy of Immunodiagnostic Tests for Active Tuberculosis Using Single and Combined Results: A Multicenter TBNET-Study

    Article • PLoS ONE, October 2008, PLOS

    PhD Ilria Sauzullo

  24. QTF-Gold assay for monitoring of anti-tuberculosis therapy in subjects with active TB

    Article • Microbiologia Medica, September 2008, PAGEPress Publications

    PhD Ilria Sauzullo

  25. Plasmacytoid Dendritic Cells Count in Antiretroviral-Treated Patients is Predictive of HIV Load Control Independent of CD4+ T-Cell Count

    Article • Current HIV Research, January 2008, Bentham Science Publishers

    PhD Ilria Sauzullo

  26. RAPIDA DIAGNOSI DI INFEZIONE DA MYCOBATTERI ATIPICI: UTILIZZO DEI KIT ARNIKA SU CAMPIONI RESPIRATORI.

    Article • Microbiologia Medica, September 2007, PAGEPress Publications

    PhD Ilria Sauzullo

  27. EFFETTO IN VITRO ED EX VIVO DEI FARMACI ANTITUBERCOLARI SUL RILASCIO DI IFN-GAMMA

    Article • Microbiologia Medica, September 2007, PAGEPress Publications

    PhD Ilria Sauzullo

  28. R2295 Study of the genotypic-resistant pattern in plasma of a group of HIV-infected Cameroonian pregnant women and children

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    PhD Ilria Sauzullo

  29. Utilizzo di nuovi test immunologici nella diagnostica dell’infezione da M. tuberculosis

    Article • Microbiologia Medica, December 2006, PAGEPress Publications

    PhD Ilria Sauzullo

  30. UTILIZZO DEL QUANTIFERON (QF)-TB GOLD IN UNA COORTE DI SOGGETTI PEDIATRICI E HIV POSITIVI

    Article • Microbiologia Medica, September 2006, PAGEPress Publications

    PhD Ilria Sauzullo

  31. UTILIZZO DEL QUANTIFERON (QF)-TB GOLD IN UNA COORTE DI SOGGETTI PEDIATRICI E HIV POSITIVI

    Article • Microbiologia Medica, September 2006, PAGEPress Publications

    PhD Ilria Sauzullo

  32. HIV protease inhibitor therapy reverses neutrophil apoptosis in AIDS patients by direct calpain inhibition

    Article • APOPTOSIS, March 2006, Springer Science + Business Media

    PhD Ilria Sauzullo

  33. UTILIZZO DI NUOVI TEST IMMUNOLOGICI NELLA DIAGNOSTICA DELL’INFEZIONE E MALATTIA DA M.TUBERCULOSIS

    Article • Microbiologia Medica, September 2005, PAGEPress Publications

    PhD Ilria Sauzullo